# REVIVA PHARMACEUTCLS HLDGS I (RVPHW)

> Institutional ownership reported to the SEC as of Q3 2025, from Form 13F filings. Source: https://holderbook.com/stocks/RVPHW/

- Reporting holders: 2
- Reported value: $12.8K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](https://holderbook.com/funds/1446194-susquehanna-international-group-llp/) | $10.8K | 134,668 | 0.0% | 2 |
| [Virtu Financial LLC](https://holderbook.com/funds/1533964-virtu-financial-llc/) | $2.0K | 20,383 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2025 | 2 | $12.8K |
| Q2 2025 | 3 | $493 |
| Q1 2025 | 1 | $1.0K |
| Q4 2024 | 2 | $628 |
| Q3 2024 | 3 | $8.1K |
| Q2 2024 | 4 | $38.6K |
| Q1 2024 | 5 | $112.5K |
| Q4 2023 | 3 | $203.2K |
| Q3 2023 | 4 | $239.5K |
| Q2 2023 | 3 | $254.0K |
| Q1 2023 | 4 | $180.2K |
| Q4 2022 | 4 | $191.5K |